MAIA Biotechnology Files 8-K on Material Agreement
Ticker: MAIA · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1878313
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
TL;DR
MAIA Bio filed an 8-K for a material agreement, unregistered equity sales, and financials.
AI Summary
On June 17, 2025, MAIA Biotechnology, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equity securities and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Chicago, IL.
Why It Matters
This filing indicates significant corporate activity, potentially involving new agreements or transactions that could impact the company's financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Numbers
- 2834 — SIC Code (Pharmaceutical Preparations industry)
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Address of principal executive offices
- 001-41455 (identifier) — Commission File Number
FAQ
What is the nature of the material definitive agreement filed by MAIA Biotechnology, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
What are the key items reported in this 8-K filing?
The key items reported are the entry into a material definitive agreement, unregistered sales of equity securities, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 17, 2025.
Where are MAIA Biotechnology, Inc.'s principal executive offices located?
MAIA Biotechnology, Inc.'s principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is MAIA Biotechnology, Inc.'s Standard Industrial Classification (SIC) code?
MAIA Biotechnology, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding MAIA Biotechnology, Inc. (MAIA).